HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Yin Selected Research

Annexin A3

1/2015Annexin A3 Is a Potential Predictor of Platinum Resistance in Epithelial Ovarian Cancer Patients in a Prospective Cohort.
2/2012Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients.
2/2010Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Yin Research Topics

Disease

92Neoplasms (Cancer)
11/2022 - 09/2008
29Inflammation (Inflammations)
04/2022 - 06/2015
23Hepatocellular Carcinoma (Hepatoma)
03/2022 - 07/2006
19Body Weight (Weight, Body)
04/2022 - 01/2013
19Infections
03/2022 - 06/2011
18Stomach Neoplasms (Stomach Cancer)
07/2022 - 06/2010
14Carcinogenesis
05/2022 - 11/2007
12Myocardial Infarction
01/2022 - 01/2014
12Neoplasm Metastasis (Metastasis)
03/2020 - 02/2014
9Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 01/2017
8Diarrhea
01/2022 - 01/2016
8Ovarian Neoplasms (Ovarian Cancer)
04/2019 - 02/2010
7Adenocarcinoma
11/2022 - 12/2017
7Colitis
04/2022 - 01/2014
7Autoimmune Diseases (Autoimmune Disease)
12/2021 - 10/2015
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2011
7Weight Gain
05/2020 - 04/2014
7Lung Neoplasms (Lung Cancer)
01/2020 - 04/2013
7Infarction (Infarctions)
01/2019 - 01/2014
7Ischemia
01/2018 - 06/2013
6Obesity
10/2020 - 12/2016
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2012
5Dysbiosis
05/2022 - 01/2016
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 12/2015
5Cardiac Arrhythmias (Arrythmia)
01/2022 - 05/2015
5Pain (Aches)
12/2019 - 10/2014
4Thrombotic Thrombocytopenic Purpura
03/2022 - 11/2018
4Fibrosis (Cirrhosis)
01/2022 - 01/2019
4Neuroblastoma
01/2022 - 05/2016
4Ovarian Epithelial Carcinoma
01/2022 - 01/2015
4Neuroinflammatory Diseases
06/2020 - 05/2016
4Breast Neoplasms (Breast Cancer)
02/2018 - 01/2013
4Brain Injuries (Brain Injury)
01/2018 - 06/2013
4Hypoxia (Hypoxemia)
12/2017 - 06/2015
4Wounds and Injuries (Trauma)
02/2017 - 01/2014
3Fatigue
11/2022 - 10/2014
3Asthma (Bronchial Asthma)
02/2022 - 05/2017
3Adenocarcinoma of Lung
01/2022 - 04/2013
3Leukemia
01/2022 - 01/2011
3Carcinoma (Carcinomatosis)
12/2021 - 01/2014
3COVID-19
10/2021 - 01/2020
3Atherosclerosis
01/2021 - 01/2019
3Cerebral Infarction
01/2021 - 04/2014
3Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 12/2018
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 03/2015

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
07/2022 - 06/2011
21Pharmaceutical PreparationsIBA
01/2022 - 01/2011
16Messenger RNA (mRNA)IBA
04/2022 - 08/2007
14Biological ProductsIBA
06/2022 - 06/2009
14CytokinesIBA
04/2022 - 01/2014
12Long Noncoding RNAIBA
01/2022 - 09/2016
12MicroRNAs (MicroRNA)IBA
12/2021 - 01/2012
11Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2010
11EnzymesIBA
12/2021 - 04/2008
11Amino AcidsFDA Link
10/2020 - 01/2013
8Cisplatin (Platino)FDA LinkGeneric
04/2021 - 04/2013
8Small Interfering RNA (siRNA)IBA
04/2021 - 06/2010
8AntioxidantsIBA
01/2021 - 12/2013
7NF-kappa B (NF-kB)IBA
01/2022 - 06/2007
7PlatinumIBA
10/2021 - 02/2010
7Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 01/2016
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 06/2007
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
6Peptides (Polypeptides)IBA
10/2021 - 01/2011
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2012
6MelatoninIBA
10/2020 - 04/2017
6Interleukin-17 (Interleukin 17)IBA
07/2020 - 01/2014
5Dextrans (Dextran)FDA Link
04/2022 - 12/2015
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2014
5LeptinIBA
10/2020 - 08/2007
5Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 11/2012
5Insulin (Novolin)FDA Link
03/2018 - 01/2014
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2022 - 12/2015
4IronIBA
03/2022 - 06/2019
4InterferonsIBA
01/2022 - 01/2015
4LigandsIBA
12/2021 - 01/2011
4Fluorouracil (Carac)FDA LinkGeneric
04/2021 - 01/2012
4CateninsIBA
01/2021 - 07/2017
4von Willebrand FactorIBA
01/2019 - 06/2015
4Glutamine (L-Glutamine)FDA Link
12/2017 - 01/2013
3Lysine (L-Lysine)FDA Link
07/2022 - 01/2018
3thiamine triphosphorate (TTP)IBA
03/2022 - 11/2018
3Adenosine Triphosphate (ATP)IBA
01/2022 - 01/2017
3AntibodiesIBA
12/2021 - 01/2021
3ImmunosorbentsIBA
12/2021 - 02/2012
3AntigensIBA
05/2021 - 12/2015
3F(6) ATPaseIBA
05/2021 - 01/2016
3VaccinesIBA
01/2021 - 10/2014
3CollagenIBA
01/2021 - 12/2016
3RotenoneIBA
06/2020 - 05/2019
3ZincIBA
01/2020 - 04/2014
3NucleotidesIBA
01/2019 - 11/2017

Therapy/Procedure

39Therapeutics
11/2022 - 01/2010
12Drug Therapy (Chemotherapy)
01/2021 - 11/2010
8Immunotherapy
01/2022 - 12/2015
4Transplantation
01/2021 - 01/2014
4Neoadjuvant Therapy
03/2016 - 12/2015
3Laparotomy
01/2022 - 07/2019
3Lymph Node Excision (Lymph Node Dissection)
01/2021 - 02/2015
3Adjuvant Chemotherapy
01/2020 - 01/2017